Informing on health and wellness news in Anguilla

Provided by AGP

Anguilla Healthcare Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Anguilla Healthcare Digest.

Press releases published on May 8, 2026

Avicanna Announces Results of Annual General and Special Meeting
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections
Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update
Treace Medical Concepts Reports First Quarter 2026 Financial Results
OXB to exhibit and present at the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT)
Le Consortium international de recherche sur le cancer de l’ovaire annonce une nouvelle bourse pour des recherches propulsées par l’IA, visant à faire progresser les découvertes fondées sur les données
Global Ovarian Cancer Research Consortium Announces Next AI Accelerator Grant to Advance Data-Driven Discovery
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years
Hyperion DeFi Announces Closing of Public Offering of Common Stock
Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update
MapLight Therapeutics to Participate in Upcoming Investor Conferences
Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance
Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights
Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil
Thérapeutique Knight annonce l’approbation réglementaire de TAVALISSE® au Brésil
Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026
Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology

Share us

on your social networks:

Sign up for:

Anguilla Healthcare Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.